John S. Montalbano - 10 Mar 2025 Form 4 Insider Report for AbCellera Biologics Inc. (ABCL)

Role
Director
Signature
Tryn Stimart, attorney-in-fact
Issuer symbol
ABCL
Transactions as of
10 Mar 2025
Net transactions value
+$57,500
Form type
4
Filing time
10 Mar 2025, 17:11:03 UTC
Previous filing
07 Mar 2025
Next filing
16 Jun 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABCL Common Shares Purchase $57,500 +25,000 +17% $2.30 171,000 10 Mar 2025 Direct
holding ABCL Common Shares 5,000 10 Mar 2025 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.